Navin Fluorine International Limited
Outcome of Board Meeting
Navin Fluorine International Limited has submitted its financial results for the period ended September 30, 2026.
BSE & NSE corporate filings with AI summaries
Navin Fluorine International Limited
Navin Fluorine International Limited has submitted its financial results for the period ended September 30, 2026.
Premier Synthetics Ltd
Premier Synthetics Ltd has scheduled a Board Meeting on 14/11/2026 to consider and approve unaudited financial statement for the quarter and half year ended on 30th September, 2026.
JSW Holdings Limited
JSW Holdings Limited has informed the Exchange about Copy of Newspaper Publication containing an extract of the Unaudited Standalone and Consolidated Financial Results for the Second Quarter and Half Year ended September 30, 2026, published in Financial Express (English) and Mumbai Lakshadweep (Marathi).
Navin Fluorine International Ltd-$
Navin Fluorine International Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with a profit after tax of ₹512.55 crore. The company has also declared an interim dividend of ₹8 per equity share for the Financial Year 2026-27.
Pune E - Stock Broking Ltd
Pune E-Stock Broking Ltd has announced its half-yearly financial results for the period ended September 30, 2026, and approved the related party transactions for the same period. The company's board of directors has also considered and approved the audited standalone and consolidated financial results for the half year ended September 30, 2026.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has announced its Q2 FY27 financial and operating results, with network gross revenue growing 20% YoY to ₹ 3,219 Cr and PAT increasing 10% YoY to ₹ 448 Cr.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced the outcome of its board meeting held on October 30, 2026, where it approved the unaudited standalone & consolidated financial results for the quarter and half year ended September 30, 2026. The company also approved capital expenditure of ₹93 Crore and ₹97 Crore for the expansion of Max Super Speciality Hospital, Sector-128, Noida and Max Super Speciality Hospital, Vaishali respectively. Additionally, the board approved the appointment of Dr. Dharmender Kumar as Director & Chief - Public Affairs and revised the project cost to ₹1,143 Crore for the construction of a ~525 bedded hospital at Sector - 56, Gurugram.
HCP Plastene Bulkpack Ltd
HCP Plastene Bulkpack Ltd has scheduled a Board Meeting on 06/11/2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended on 30/09/2026.
Globus Spirits Ltd
Globus Spirits Ltd has released its Q2 H1 FY 27 investor presentation, highlighting key performance metrics and financial highlights. The company reported a 9% increase in net revenue from operations and a 2% increase in PAT margin in Q2 FY 27. The presentation also discussed the company's investment thesis, focusing on its consumer alco-bev platform with resilient cash flows, premiumization upside, and disciplined capital allocation.
Dhanuka Agritech Limited
Dhanuka Agritech Limited has informed the Exchange about Investor Presentation for Q2 FY 2026-2027, discussing the company's performance amidst a weak and subdued earnings season due to erratic monsoon rainfall and high raw material costs.
Jain Marmo Industries Ltd
Jain Marmo Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/11/2026 to consider and approve Unaudited Financial Results for the Quarter and half year ended on 30th September 2026.
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd has announced its financial results for the quarter and half year ended September 30, 2026, with the board of directors approving capital expenditure for the expansion of two hospitals and the appointment of a senior management personnel. The company has also revised the project cost and timeline for the construction of a new hospital in Gurugram.
Bright Brothers Ltd-$
Bright Brothers Ltd has announced its unaudited financial results for the second quarter and half year ended 30th September 2026, with revenue from operations at ₹10,770 lakhs and ₹35,993 lakhs for the quarter and half year respectively.
Max Healthcare Institute Limited
Max Healthcare Institute Limited has announced its financial results for the quarter and half year ended September 30, 2026, and approved capital expenditure for the expansion of two of its hospitals. The company also appointed a new senior management personnel and updated on the construction of a new hospital.
Bharat Gears Limited
Bharat Gears Limited has submitted its un-audited financial results for the quarter ended September 30, 2026, along with a limited review report. The results were approved by the Board of Directors at their meeting on October 30, 2026. The review report highlights concerns raised by the erstwhile Joint Managing Director regarding certain practices by the Chairman and Managing Director, which are being assessed by the Management and Audit Committee.
Ultracab (India) Ltd
Ultracab (India) Ltd has scheduled a Board Meeting on November 04, 2026, to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026.
Gail (India) Ltd
Gail (India) Ltd has announced its un-audited financial results for the quarter and half year ended 30.09.2026, which were approved by the Board of Directors. The results are in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Hariom Pipe Industries Ltd
Hariom Pipe Industries Ltd has announced a conference call on November 05, 2026, to discuss its Q2 and H1 FY27 financial performance.
Globus Spirits Limited
Globus Spirits Limited has released an investor presentation for Q2 & H1 FY27, highlighting financial highlights, key performance metrics, and segment performance.
Avadh Sugar & Energy Ltd
Avadh Sugar & Energy Ltd has scheduled a Board Meeting on 5th November, 2026 to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th September, 2026.